Discovery and validation of a new class of small molecule Toll-like receptor 4 (TLR4) inhibitors.

Por Matthew D Neal, Hongpeng Jia, Benjamin Eyer, Misty Good, Christopher J Guerriero, Chhinder P Sodhi, Amin Afrazi, Thomas Prindle, Congrong Ma, Maria Branca, John Ozolek, Jeffrey L Brodsky, Peter Wipf, David J Hackam
Publicado em 2013-01-01